BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4343295)

  • 21. [Indications and results of surgical treatment of bronchial cancer including small-cell carcinoma].
    Vogt-Moykopf I; Bülzebrück H; Krysa S; Probst G; Bauer E; Stoelben E
    Verh Dtsch Ges Inn Med; 1990; 96():242-6. PubMed ID: 1965461
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma.
    Holoye PY
    Exp Hematol; 1985; 13 Suppl 16():72-9. PubMed ID: 2985416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bronchial carcinoma from the surgical viewpoint].
    Denck H; Kutschera W
    Onkologie; 1984 Oct; 7(5):263-6. PubMed ID: 6096780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchogenic carcinoma: nitrogen mustard as a surgical adjuvant and factors influencing survival. University surgical adjuvant lung project.
    Slack NH
    Cancer; 1970 May; 25(5):987-1002. PubMed ID: 4315360
    [No Abstract]   [Full Text] [Related]  

  • 25. Long term survivors after resection of bronchial carcinoma.
    Shields TW; Robinette CD
    Surg Gynecol Obstet; 1973 May; 136(5):759-62. PubMed ID: 4349729
    [No Abstract]   [Full Text] [Related]  

  • 26. Status report of adjuvant cancer chemotherapy trials in the treatment of bronchial carcinoma.
    Shields TW
    Cancer Chemother Rep 3; 1973 Mar; 4(2):119-24. PubMed ID: 4729315
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemotherapy in bronchogenic carcinoma (author's transl)].
    Bruntsch U
    Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclophosphamide plus emetine in lung cancer.
    Hyde KR; Marsh K; Perry W
    Lancet; 1972 Aug; 2(7774):427. PubMed ID: 4115244
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic factors in surgical treatment of bronchogenic carcinoma.
    Lee YT
    Surg Gynecol Obstet; 1972 Dec; 135(6):961-75. PubMed ID: 4343701
    [No Abstract]   [Full Text] [Related]  

  • 32. Methotrexate in the chemotherapy of lung cancer.
    Smyth JF; Ford HT
    Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of myelosuppression on the response to chemotherapy in small cell bronchogenic carcinoma.
    Holoye PY; Kalbfleisch J
    Cancer; 1984 Aug; 54(3):411-5. PubMed ID: 6329504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical trial of cyclophosphamide (NSC-26271) and radiation therapy for oat cell carcinoma of the lung.
    Tucker RD; Sealy R; van Wyk C; le Roux PL; Soskolne CL
    Cancer Chemother Rep 3; 1973 Mar; 4(2):159-60. PubMed ID: 4354040
    [No Abstract]   [Full Text] [Related]  

  • 35. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
    Alberto P
    Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.
    Maurer LH; Tulloh M; Eagan RT; Forcier RJ; House R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):171-6. PubMed ID: 4354041
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of adjuvant surgery in the combined modality therapy of small-cell bronchogenic carcinoma after a chemotherapy-induced partial remission.
    Holoye PY; McMurtrey MJ; Mountain CF; Murphy WK; Dhingra HM; Umsawasdi T; Glisson BS; Lee JS; Carr DT; Valdivieso M
    J Clin Oncol; 1990 Mar; 8(3):416-22. PubMed ID: 2307986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic results in small-cell bronchial carcinoma after ACO II chemotherapy and adjuvant radiation].
    Leipner N; Harder T; Hövelmann B; Schüller H; Hartlapp JH; Boldt I
    Strahlenther Onkol; 1987 Oct; 163(10):637-42. PubMed ID: 2823403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surgical treatment of small-cell bronchial carcinoma].
    Baudrexl A; Wilde I; Eule H; Dippmann A; Haenselt V; Baudrexl L; Bieselt R; Brethner J; Haupt R; Wilde I
    Arch Geschwulstforsch; 1984; 54(1):61-7. PubMed ID: 6322722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unfavourable effects of long-term adjuvant chemotherapy with Endoxan in radically operated bronchogenic carcinoma.
    Brunner KW; Marthaler T; Müller W
    Eur J Cancer (1965); 1971 Aug; 7(4):285-94. PubMed ID: 5570706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.